Clinical Trial Update: Evaluation of the Role of Low Dose Magnesium Sulfate in Anesthesia for Toxic Goiter Resection [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating low-dose magnesium sulfate in anesthesia for toxic goiter resection has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Haemodynamic Instability
• Toxic Goiter

Drugs mentioned

• Magnesium sulfate (magnesium sulfate)

Snippet

Sponsor: Fayoum University Hospital | Conditions: Haemodynamic Stability | Phase 4 | Status: COMPLETED